These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6217939)

  • 1. Contrasting effects of prostaglandin E2 and indomethacin in modulating Con A-induced human lymphocyte proliferation and suppressor cell development.
    Skoldstam L; Zoschke D; Messner R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):32-42. PubMed ID: 6217939
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of prostaglandin E2 and preincubation on lectin-stimulated proliferation of human T cell subsets.
    Gualde N; Goodwin JS
    Cell Immunol; 1982 Jul; 70(2):373-9. PubMed ID: 6215130
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of conconavalin-A-induced suppressor cell activation by prostaglandin E2.
    Goodwin JS
    Cell Immunol; 1980 Feb; 49(2):421-5. PubMed ID: 6444371
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis.
    Gordon D; Henderson DC; Westwick J
    Br J Pharmacol; 1979 Sep; 67(1):17-22. PubMed ID: 387146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
    Fischer A; Durandy A; Griscelli C
    J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
    Balch CM; Dougherty PA; Cloud GA; Tilden AB
    Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression.
    Kallenberg CG; de Gast GC; The TH
    Clin Exp Immunol; 1980 Sep; 41(3):583-90. PubMed ID: 6449339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of preincubated lymphocytes to suppressor regulation.
    Kalmár L; Gergely P; Nékám K; Gonzalez R
    Acta Med Hung; 1983; 40(4):195-202. PubMed ID: 6232498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of newborns' or pregnant women's monocytes to suppress pokeweed mitogen-induced responses.
    Durandy A; Fischer A; Griscelli C
    J Immunol; 1982 Feb; 128(2):525-9. PubMed ID: 6459380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2-mediated enhancement of human plasma cell differentiation.
    Lydyard PM; Brostoff J; Hudspith BN; Parry H
    Immunol Lett; 1982 Mar; 4(3):113-6. PubMed ID: 6210627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
    Murray JL; Dowd J; Hersh EM
    J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of indomethacin on T lymphocyte stimulation.
    Kingston AE; Ivanyi J; Kay JE
    Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.
    Hudspith BN; Brostoff J; McNicol MW; Johnson NM
    Clin Exp Immunol; 1984 Aug; 57(2):324-30. PubMed ID: 6331921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the mitogenic response of lymphocytes from young and aged individuals by prostaglandins and indomethacin.
    Rao KM; Schwartz SA; Good RA
    Cell Immunol; 1979 Nov; 48(1):155-65. PubMed ID: 509534
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of indomethacin on lymphocyte proliferation, suppressor cell function, and leukocyte migration inhibitory factor (lmif) production.
    Soppi E; Eskola J; Ruuskanen O
    Immunopharmacology; 1982 Jun; 4(3):235-42. PubMed ID: 6213582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects exerted by prostaglandins and indomethacin on the immune response during aging.
    Licastro F; Walford RL
    Gerontology; 1986; 32(1):1-9. PubMed ID: 3456337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432.
    Toge T; Yamada H; Aratani K; Yamaguchi M; Fujita T; Yanagawa E; Hattori T
    Int J Immunopharmacol; 1987; 9(8):875-9. PubMed ID: 2892805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved renal allograft function and survival following nonspecific blood transfusions. I. Induction of soluble suppressor factors inhibiting the mitogenic response.
    Roy R; Lachance JG; Noel R; Grose JH; Beaudoin R
    Transplantation; 1986 May; 41(5):640-3. PubMed ID: 2939609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity.
    Ceuppens JL; Goodwin JS
    Cell Immunol; 1982 Jun; 70(1):41-54. PubMed ID: 6214316
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of indomethacin administration during pregnancy on women's and newborns' T-suppressor lymphocyte activity and on HLA class II expression by newborns' leukocytes.
    Durandy A; Brami C; Griscelli C
    Am J Reprod Immunol Microbiol; 1985 Jul; 8(3):94-100. PubMed ID: 3161348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.